129 related articles for article (PubMed ID: 36693216)
1. Physicochemical Characterization of Ferrocifen Lipid Nanocapsules: Customized Drug Delivery Systems Guided by the Molecular Structure.
Idlas P; Lepeltier E; Bastiat G; Pigeon P; McGlinchey MJ; Lautram N; Vessières A; Jaouen G; Passirani C
Langmuir; 2023 Feb; 39(5):1885-1896. PubMed ID: 36693216
[TBL] [Abstract][Full Text] [Related]
2. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
[TBL] [Abstract][Full Text] [Related]
3. Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant Tumors.
Idlas P; Lepeltier E; Jaouen G; Passirani C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064748
[TBL] [Abstract][Full Text] [Related]
4. Ferrocifen stealth LNCs and conventional chemotherapy: A promising combination against multidrug-resistant ovarian adenocarcinoma.
Idlas P; Ladaycia A; Némati F; Lepeltier E; Pigeon P; Jaouen G; Decaudin D; Passirani C
Int J Pharm; 2022 Oct; 626():122164. PubMed ID: 36089209
[TBL] [Abstract][Full Text] [Related]
5. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
[TBL] [Abstract][Full Text] [Related]
7. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
[TBL] [Abstract][Full Text] [Related]
8. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters.
Aparicio-Blanco J; Sebastián V; Benoit JP; Torres-Suárez AI
Eur J Pharm Biopharm; 2019 Jan; 134():126-137. PubMed ID: 30472144
[TBL] [Abstract][Full Text] [Related]
10. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules as in vivo oxygen sensors using magnetic resonance imaging.
Nel J; Franconi F; Joudiou N; Saulnier P; Gallez B; Lemaire L
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():396-403. PubMed ID: 31029333
[TBL] [Abstract][Full Text] [Related]
13. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
15. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
[TBL] [Abstract][Full Text] [Related]
16. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
17. An
Radwan Y; Arafa KK; Ghoniem MG; Al-Farraj ES; El-Sherbiny IM
Drug Dev Ind Pharm; 2023 Mar; 49(3):271-280. PubMed ID: 37067846
[TBL] [Abstract][Full Text] [Related]
18. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
Allard E; Jarnet D; Vessières A; Vinchon-Petit S; Jaouen G; Benoit JP; Passirani C
Pharm Res; 2010 Jan; 27(1):56-64. PubMed ID: 19908129
[TBL] [Abstract][Full Text] [Related]
20. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
